Ed Mathers

Board Member

Ed Mathers joined NEA as a partner in August 2008 and is focused on biotechnology and specialty pharmaceuticals investments. He is a director of Liquidia Technologies, Ra Pharmaceuticals (NASDAQ:RARX), Rhythm Pharmaceuticals, Envisia Therapeutics, Synlogic,(NASDAQ:SYBX), Lumos Pharma, Amplyx Pharmaceuticals, Senti Biosciences, Inozyme, Akouos, T...

Roles at Reneo Pharmaceuticals

  • Board Member

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.